Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12605000239662
Ethics application status
Approved
Date submitted
24/08/2005
Date registered
31/08/2005
Date last updated
14/09/2007
Type of registration
Retrospectively registered
Titles & IDs
Public title
The value of an advance notification letter prior to a postal offer of bowel cancer screening on population participation in screening.
Query!
Scientific title
The value of an advance notification letter prior to a postal offer of bowel cancer screening on population participation in screening.
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Screening for bowel cancer
325
0
Query!
Condition category
Condition code
Cancer
371
371
0
0
Query!
Bowel - Anal
Query!
Cancer
372
372
0
0
Query!
Bowel - Back passage (rectum) or large bowel (colon)
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
A bowel cancer screening program that incorporates a preliminary letter to notify an invitee that they will be shortly sent an invitation to participate.
Query!
Intervention code [1]
246
0
Behaviour
Query!
Comparator / control treatment
An offer that does not include the preliminary letter.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
432
0
Completion of faecal immunochemical test expressed as the population participation rate.
Query!
Assessment method [1]
432
0
Query!
Timepoint [1]
432
0
Within 12 weeks of offer.
Query!
Secondary outcome [1]
945
0
Test positivity rate
Query!
Assessment method [1]
945
0
Query!
Timepoint [1]
945
0
12 weeks from invitation
Query!
Secondary outcome [2]
946
0
Yield of neoplasia
Query!
Assessment method [2]
946
0
Query!
Timepoint [2]
946
0
12 weeks from invitation
Query!
Eligibility
Key inclusion criteria
Present on the electoral roll of the Australian Electoral Commission, who reside in one of a set of defined postcodes adjacent to Flinders Medical Centre or Repatriation General Hospital Daw Park.
Query!
Minimum age
50
Years
Query!
Query!
Maximum age
74
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
People already participating in bowel cancer screening research and service programs coordinated from the Bowel Health Service, Repartiation General Hospital Daw Park.Self exclusion by invitees - people who have specific heart and lung conditions that would preclude them from diagnostic and surgical follow-up following a positive screening test. All people who have specific medical conditions that would invalidate the screening test results. All people who have had a colonoscopy or stool screening test within the last year.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Invitees are randomised to a screening program with preliminary notification letter or without. Invitations to participate are sent by mail, there is no direct interpersonal contact. Help line calls are answered without knowledge of intervention group.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Group sizes of 600 each were determined by power analysis assuming that an intervention that produces a 10% increase in participation over control is a significant program improvement. All eligible people were assigned a random number using the MicroSoft Excel RAND function. The listing was ordered by ascending random number. The first 600 people were assigned to the intervention group, the second 600 to control group.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Date of first participant enrolment
Anticipated
1/01/2005
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
1200
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
430
0
Government body
Query!
Name [1]
430
0
NHMRC Project grant 324717
Query!
Address [1]
430
0
GPO Box 1421
Canberra ACT 2601
Query!
Country [1]
430
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Prof. Graeme Young MD, FRACP
Query!
Address
Dept of Gastroenterology
Flinders Medical Centre
Query!
Country
Australia
Query!
Secondary sponsor category [1]
348
0
Individual
Query!
Name [1]
348
0
Mr Stephen Cole
Query!
Address [1]
348
0
Bowel Health Service
Repatriation General Hospital
Query!
Country [1]
348
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
1400
0
Repatriation General Hospital Daw Park
Query!
Ethics committee address [1]
1400
0
Daws Rd, Daw Park, SA 5041
Query!
Ethics committee country [1]
1400
0
Australia
Query!
Date submitted for ethics approval [1]
1400
0
Query!
Approval date [1]
1400
0
Query!
Ethics approval number [1]
1400
0
Query!
Summary
Brief summary
Improved participation in screening for bowel cancer is desirable. Currently population scale bowel cancer screening program delivery is by mailed offer, without prior warning, from a central screening service and invitations include a occult blood kit. Invitees may reject this process as they are unprepared to receive such an offer. One approach is to improve communication between screening providers and invitees through improved population scale interpersonal contact. We have developed a preliminary letter to precede an postal invitation to bowel cancer screening. The letter simply informs invitees that they will soon receive a screening invitation and provides them with some basic information about bowel cancer screening. We will randomly select invitees from the electoral roll and compare population screening participation between groups with or without the preliminary letter to determine which program results in the greater participation rate. Improved participation in screening will ultimately reduce deaths from bowel cancer
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
35912
0
Query!
Address
35912
0
Query!
Country
35912
0
Query!
Phone
35912
0
Query!
Fax
35912
0
Query!
Email
35912
0
Query!
Contact person for public queries
Name
9435
0
Ms Alicia Smith
Query!
Address
9435
0
Bowel Health Service
Repatriation General Hospital Daw Park
Daws Rd
Daw Park SA 5041
Query!
Country
9435
0
Australia
Query!
Phone
9435
0
+61 8 82751075
Query!
Fax
9435
0
+61 8 82751083
Query!
Email
9435
0
[email protected]
Query!
Contact person for scientific queries
Name
363
0
Mr Stephen Cole
Query!
Address
363
0
Bowel Health Service
Repatriation General Hospital Daw Park
Daws Rd
Daw Park SA 5041
Query!
Country
363
0
Australia
Query!
Phone
363
0
+61 8 82751838
Query!
Fax
363
0
+61 8 82751083
Query!
Email
363
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF